Interestingly, the latter study on CA9 in breast cancer (Bartosova et al, 2002) reported a, albeit weak, correlation with Her2/neu, which is known to be associated with the acquirement of hormone insensitivity in breast tumours. This evidence concerns the gene ERBB2 and breast carcinoma.